ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
PowerUp Acquisition Corporation

PowerUp Acquisition Corporation (PWUP)

12.65
2.25
(21.63%)
종가: 06 2월 6:00AM
12.65
0.00
( 0.00% )
시간외 거래: 6:13AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
12.65
매수가
9.66
매도가
13.88
거래량
1,555
10.51 일간 변동폭 13.03
9.00 52주 범위 14.47
market_cap
전일 종가
10.40
개장가
10.51
최근 거래 시간
1
@
10.85
마지막 거래 시간
06:22:48
재정 규모
US$ 19,650
VWAP
12.6367
평균 볼륨(3m)
1,453
발행 주식
8,991,229
배당수익률
-
주가수익률
25.48
주당순이익(EPS)
0.5
매출
-
순이익
4.46M

PowerUp Acquisition Corporation 정보

PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

섹터
Pharmaceutical Preparations
산업
Blank Checks
본부
Grand Cayman, Cym
설립됨
2023
PowerUp Acquisition Corporation is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker PWUP. The last closing price for PowerUp Acquisition was US$10.40. Over the last year, PowerUp Acquisition shares have traded in a share price range of US$ 9.00 to US$ 14.47.

PowerUp Acquisition currently has 8,991,229 shares in issue. The market capitalisation of PowerUp Acquisition is US$93.51 million. PowerUp Acquisition has a price to earnings ratio (PE ratio) of 25.48.

PWUP 최신 뉴스

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing...

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent protected disruptive drug delivery...

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that, on June 3, 2024, the Company received a notice (the “Notice”) from...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”...

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) and Visiox Pharmaceuticals, Inc. (“Visiox”), a commercial-stage...

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.958.1196581196611.713.99756011.9721073CS
41.2210.673665791811.4313.99429811.8766099CS
121.05749.1213360247111.592613.99145311.84834056CS
261.399912.443444947211.250114.479138011.77273683CS
521.7415.948670944110.9114.479795111.33189184CS
1562.6526.51014.4794356110.41778476CS
2602.6526.51014.4794356110.41778476CS

PWUP - Frequently Asked Questions (FAQ)

What is the current PowerUp Acquisition share price?
The current share price of PowerUp Acquisition is US$ 12.65
How many PowerUp Acquisition shares are in issue?
PowerUp Acquisition has 8,991,229 shares in issue
What is the market cap of PowerUp Acquisition?
The market capitalisation of PowerUp Acquisition is USD 93.51M
What is the 1 year trading range for PowerUp Acquisition share price?
PowerUp Acquisition has traded in the range of US$ 9.00 to US$ 14.47 during the past year
What is the PE ratio of PowerUp Acquisition?
The price to earnings ratio of PowerUp Acquisition is 25.48
What is the reporting currency for PowerUp Acquisition?
PowerUp Acquisition reports financial results in USD
What is the latest annual profit for PowerUp Acquisition?
The latest annual profit of PowerUp Acquisition is USD 4.46M
What is the registered address of PowerUp Acquisition?
The registered address for PowerUp Acquisition is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
Which industry sector does PowerUp Acquisition operate in?
PowerUp Acquisition operates in the BLANK CHECKS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
IVVDInvivyd Inc
US$ 3.0497
(44.54%)
9.57M
SBETSharpLink Gaming Inc
US$ 0.5794
(37.95%)
3.42M
RANIRani Therapeutics Holdings Inc
US$ 1.97
(36.81%)
9.2M
APPSDigital Turbine Inc
US$ 3.3484
(31.83%)
4.46M
TTMITTM Technologies Inc
US$ 28.5801
(15.34%)
31.4k
FORMFormFactor Inc
US$ 30.08
(-26.85%)
120.61k
KTTAPasithea Therapeutics Corporation
US$ 2.06
(-24.82%)
978.91k
PIImpinj Inc
US$ 96.49
(-24.06%)
240.57k
SWKSSkyworks Solutions Inc
US$ 67.3975
(-22.60%)
1.27M
AVGRAvinger Inc
US$ 0.44
(-21.41%)
183.76k
IVVDInvivyd Inc
US$ 3.04
(44.08%)
9.57M
RIMEAlgorhythm Holdings Inc
US$ 0.0209
(0.00%)
9.28M
RANIRani Therapeutics Holdings Inc
US$ 1.9799
(37.49%)
9.2M
CYNCYNGN Inc
US$ 0.0813
(-0.85%)
8.06M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.052799
(1.54%)
6.47M

PWUP Discussion

게시물 보기
barnyarddog barnyarddog 3 주 전
PowerUp will hold an extraordinary general meeting..... to consider matters relating to the Business Combination at 9:00 AM, Eastern Time, on February 4, 2025.

Proposal No. 1 — The Business Combination Proposal —

PowerUp has unanimously approved the Business Combination Agreement and the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and unanimously recommends that shareholders vote “FOR” the adoption of the Business Combination Agreement and approval of the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and “FOR” all other proposals presented to PowerUp’s shareholders in the proxy statement/prospectus.

424B3
01/14/2025
https://www.otcmarkets.com/filing/html?id=18106839&guid=3D0-kKRdcsFTh3h
👍️0
barnyarddog barnyarddog 2 월 전
oops
👍️0
barnyarddog barnyarddog 2 월 전
Aspire Pharma acquires Canute to expand strategic portfolio

7 October 2024
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/aspire-pharma-acquires-canute-to-expand%C2%A0strategic-portfolio/
👍️0
barnyarddog barnyarddog 2 월 전
About the Company

https://aspirebiolabs.com/about/

I dont know if this is the merging company...
👍️0
barnyarddog barnyarddog 2 월 전
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

September 03, 2024
https://www.globenewswire.com/news-release/2024/09/03/2939657/0/en/Aspire-Biopharma-Inc-and-PowerUp-Acquisition-Corp-Announce-Business-Combination-Agreement-to-Create-Nasdaq-listed-Biopharmaceutical-Company-Driving-Breakthrough-Innovations-in-FDA-.html

Aspire Overview

Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for “do no harm” FDA approved drugs, nutraceuticals and supplements. Aspire has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, patient compliance and safety and rapid response and absorption time when required and desired.
👍️0

최근 히스토리

Delayed Upgrade Clock